Abbott FCA Deal Shows Enforcement Adequacy Quandaries
By James Koukios · October 5, 2026, 3:06 PM EDT
The U.S. Department of Justice's resolution with Abbott Laboratories announced last month illustrates a recurring question in corporate enforcement: When is a civil enforcement action alone sufficient to address allegedly wrongful...
To view the full article, register now.